Page last updated: 2024-11-04

tegafur and Androgen-Independent Prostatic Cancer

tegafur has been researched along with Androgen-Independent Prostatic Cancer in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takahashi, M1
Kawabata, R1
Kawano, A1
Murakami, Y1
Sutou, Y1
Inai, T1
Akazawa, S1
Hamao, T1
Hayashi, H1
Fukawa, T1
Takemura, M1
Yamamoto, Y1
Yamaguchi, K1
Izaki, H1
Fukumori, T1
Kanayama, H1
Hayakawa, N1
Matsumoto, K1
Sato, A1
Sakamoto, H1
Ezaki, T1
Maeda, T1
Ninomiya, A1
Nakamura, S1
Takayama, T1
Sugiyama, T1
Furuse, H1
Yajima, T1
Suzuki, T1
Kai, F1
Nagata, M1
Otsuka, A1
Ishii, Y1
Ozono, S1

Trials

1 trial available for tegafur and Androgen-Independent Prostatic Cancer

ArticleYear
Substitution of anti-androgens and tegafur-uracil combination therapy for castration-resistant prostate cancer: results of a multi-center randomized phase II study.
    International journal of oncology, 2013, Volume: 43, Issue:3

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Dihyd

2013

Other Studies

2 other studies available for tegafur and Androgen-Independent Prostatic Cancer

ArticleYear
Efficacy of tegafur-uracil (UFT) administration in castration-resistant prostate cancer patients with a history of both alternative antiandrogen therapy and estramustine phosphate sodium hydrate therapy.
    International urology and nephrology, 2014, Volume: 46, Issue:6

    Topics: Age Factors; Aged; Aged, 80 and over; Androgen Antagonists; Antimetabolites, Antineoplastic; Antineo

2014
[Salvage therapy for castration-refractory prostate cancer resistant to docetaxel].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2013, Volume: 104, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials

2013